Sunday, April 4, 2021

Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India

Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said in a statement to stock exchanges.

from Moneycontrol Business News https://ift.tt/3dy39mn
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

European shares log weekly losses on Iran war-linked inflation woesdrop

European markets experienced a significant downturn, with the STOXX 600 index sliding due to escalating energy inflation fears stemming from...